Archive
Over a third of COVID-19 patients diagnosed with at least one Long-COVID symptom
News published on September 29, 2021
A new study shows that 37% of people had at least one long-COVID symptom diagnosed in the 3-6 month period after COVID-19 infection, with the commonest symptoms being breathing problems, abdominal symptoms, fatigue, pain and anxiety/depression.
Oxford Health’s work towards reducing and preventing suicide
News published on September 9, 2021
It’s World Suicide Prevention day tomorrow and we are focusing on the important work done by Oxford Health and our partners to reduce the number of people who attempt to die by suicide each year.
Combining digital and IAPT therapy can improve sleep, anxiety and depression
News published on September 7, 2021
A study by Oxford Health NHS foundation trust and digital therapeutics company Big Health has shown that combining NHS Improving Access to Psychological Therapies (IAPT) care with Sleepio, a digital therapy for insomnia, has a positive impact on the mental health of patients experiencing sleep difficulty.
Oxford Health team shortlisted for BMJ Award
News published on September 3, 2021
A team from Oxford Health have been shortlisted for a prestigious BMJ award in the digital innovation category for their work on telepsychiatry during the pandemic.
Oxford Health takes pioneering step to make research more inclusive
News published on August 5, 2021
Changes to the way the Trust contacts patients about research will ensure the opportunity to participate is available to all.
Effect of the COVID-19 Pandemic on Eating Disorders
News published on August 3, 2021
Using the electronic health records of over 5 million people aged under 30, researchers from the Oxford Health Biomedical Research Centre found that eating disorders were diagnosed significantly more commonly in 2020 than in previous years, with the rate increasing steadily throughout the year.
Novavax study results show 89.7% efficacy
News published on July 16, 2021
Results from the Novavax vaccine study recently published in the New England Journal of Medicine have shown the vaccine to have an overall efficacy of 89.7%. The vaccine has also been shown to be 83.4% effective after just one dose and 83.6% effective against the B1.1.7 variant.
Ground-breaking treatment offers new hope for patients with persecutory delusions
News published on July 9, 2021
Feeling Safe is a new treatment programme for persecutory delusions, which promises a step change in the treatment of severe mental health problems.
Oxford Health BRC wins government funding for its CHRONOS project
News published on June 18, 2021
A project using artificial intelligence to develop digital triage tools for mental health clinicians (CHRONOS) has been successful in the latest round of the Artificial Intelligence in Health and Care Award.
Treating needle fears may reduce COVID-19 vaccine hesitancy rates by 10%
News published on June 16, 2021
A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia and this may be a cause of vaccine hesitancy.